A closer look at the technologies used by Purespring Therapeutics
Purespring Therapeutics
Blood & Organ Banks · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Rolling Stock Yard, 188 York Way, London...Phone Number
+44 2038556324Website
www.purespringtx.comRevenue
$15.5 MillionIndustry
About Purespring Therapeutics
Purespring Therapeutics is a precision nephrology company focused on developing targeted, first-in-class genetic therapies aimed at preserving kidney function. The company addresses both monogenic and non-monogenic kidney diseases, particularly in large and underserved patient populations. Their innovative approach includes podocyte-targeted therapies that minimize systemic effects and aim for durable efficacy. Purespring's mission is to transform the disease trajectory for patients suffering from kidney diseases, empowering them to lead fuller, healthier lives.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Purespring Therapeutics
Compare insights from companies similar to Purespring Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Purespring Therapeutics
$15.5M
11-50
Private
$165M
2020
N/A
Purespring Therapeutics Tech Stack
Top Blood & Organ Banks Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Purespring Therapeutics
Sign Up For FreeTo access detailed company insights
Purespring Therapeutics is a precision nephrology company focused on developing targeted, first-in-class genetic therapies aimed at preserving kidney function. The company addresses both monogenic and non-monogenic kidney diseases, particularly in large and underserved patient populations. Their innovative approach includes podocyte-targeted therap... Read More
